Skip to main content

Sign up for our newsletter.

Quality journalism. Progressive values. Direct to your inbox.

Demonstrators protest Big Pharma

Demonstrators protest pharmaceutical companies' lobbying outside Pharmaceutical Research and Manufacturers of America (PhRMA) headquarters in Washington, D.C. on September 21, 2021. (Photo: Saul Loeb/AFP via Getty Images)

'Enough Is Enough': Outrage as Big Pharma Hikes Prices on 442 Drugs

"Patients are counting on Congress and the Biden administration to deliver drug pricing reforms immediately in this new year."

Jake Johnson

Patient advocates on Monday condemned the U.S. pharmaceutical industry for ushering in the new year with price hikes on more than 440 medications, a move that came as congressional Democrats' plan to lower prescription drug costs remained stuck due to Sen. Joe Manchin's persistent obstruction.

"Clearly, the need for drug pricing reform is as urgent as ever."

According to the healthcare firm GoodRx, the prices of 434 brand-name drugs and eight generic medicines were increased by an average of 5.2% and 4.2%, respectively, beginning on January 1, 2022.

The largest hike came courtesy of Pfizer, which raised the price of its anti-inflammatory medication Solu-Cortef by nearly 17%. The price boost took effect after Pfizer had a massively profitable 2021 thanks in large part to its coronavirus vaccine, which benefited from public funding and U.S. government-developed technology.

“At a time when Americans are struggling with the surging omicron variant and prices for prescription drugs that are four times what other wealthy nations pay, Big Pharma began the new year yet again hitting Americans with unjustified and widespread price hikes," David Mitchell, a cancer patient and founder of Patients for Affordable Drugs, said in a statement.

Mitchell said the price increases bolster findings of a nearly three-year House Oversight Committee probe showing that the pharmaceutical industry has "raised prices with abandon" and "manipulated the patent system" to prevent fairly priced generic competition.

"Clearly," said Mitchell, "the need for drug pricing reform is as urgent as ever—Americans are struggling to afford the medications they need and have waited too long for relief."

The Build Back Better Act, Democrats' flagship social spending and climate legislation, includes provisions that would allow Medicare to directly negotiate the prices of a limited subset of prescription drugs and penalize pharmaceutical companies that raise prices faster than the rate of inflation.

But the legislation—which the pharmaceutical industry spent big to water down and obstruct—is currently stalled in the evenly divided Senate thanks to Manchin, who is refusing to support the popular bill.

"He can't be the final word. Too much is at stake," Margarida Jorge, head of Lower Drug Prices Now, said in a statement last month after Manchin announced his opposition to the current version of the Build Back Better Act.

"The Senate must immediately find a way to lower drug prices in line with the framework agreed to by senators and the White House," Jorge added. "Families can't afford to wait."

According to a recent study conducted by the polling organization Gallup in partnership with the nonprofit West Health, roughly 15.5 million U.S. adults under the age of 65 and 2.3 million seniors were unable to afford at least one doctor-prescribed medication in 2021, a finding that bolstered calls for government action to rein in sky-high drug costs in the U.S.

A Government Accountability Office analysis released in April 2021 estimated that the U.S. pays two to four times more for prescription medications than other wealthy nations.

Mitchell said Monday that the drug pricing-related provisions of the Build Back Better Act would "directly take on Big Pharma's price gouging" and "deliver relief to patients" by capping out-of-pocket costs for Medicare Part D beneficiaries, among other changes.

"These reforms are overwhelmingly supported by more than 80% of voters—Democrats, Republicans, and Independents alike—and will fight inflation by holding the line on premiums and health care costs for patients, employers, employees, and taxpayers," Mitchell added. "Patients are counting on Congress and the Biden administration to deliver drug pricing reforms immediately in this new year."

Our work is licensed under Creative Commons (CC BY-NC-ND 3.0). Feel free to republish and share widely.

We've had enough. The 1% own and operate the corporate media. They are doing everything they can to defend the status quo, squash dissent and protect the wealthy and the powerful. The Common Dreams media model is different. We cover the news that matters to the 99%. Our mission? To inform. To inspire. To ignite change for the common good. How? Nonprofit. Independent. Reader-supported. Free to read. Free to republish. Free to share. With no advertising. No paywalls. No selling of your data. Thousands of small donations fund our newsroom and allow us to continue publishing. Can you chip in? We can't do it without you. Thank you.

'Donald Trump Has Finally Run Out of Places to Hide' as House Dems Get Tax Returns

"It's no longer a question of if he's hiding something big," one watchdog group asserted, "it's a question of what he's hiding."

Brett Wilkins ·

Democrats, Progressive Groups Push DOJ to Publish Database of 'Corporate Lawbreaking'

"The Corporate Crime Database Act will bring transparency to the corporate crime crisis so that the DOJ and other law enforcement agencies can better reckon with this greed-driven menace," said one advocate.

Kenny Stancil ·

As Corporations Enjoy Record-High Profits, Experts Urge Congress to 'Rein Them In'

"Today's record corporate profits mirror what we have been hearing on earnings call after earnings call: Corporations are gleefully reporting that their strategy to burden families with unnecessary price hikes is working."

Brett Wilkins ·

'Egregious': PFAS Firefighting Foam Spills at Notorious Red Hill Naval Facility in Hawaii

While officials said there is no evidence that drinking water was contaminated, the incident generated further local frustration with the closing fuel storage complex.

Jessica Corbett ·

House Passes Paid Sick Leave for Railway Workers Despite Opposition of 207 Republicans

"Now let's get it through the Senate," said Rep. Jamaal Bowman, who led the fight to add seven days of paid sick leave to a White House-brokered contract that failed to provide any to railroad workers.

Kenny Stancil ·

Common Dreams Logo